Page last updated: 2024-08-22

rhenium and etidronate

rhenium has been researched along with etidronate in 81 studies

Research

Studies (81)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (4.94)	18.7374
1990's	36 (44.44)	18.2507
2000's	38 (46.91)	29.6817
2010's	2 (2.47)	24.3611
2020's	1 (1.23)	2.80

Authors

Authors	Studies
Berger, M; Chevalier, P; Galy, G; Mathieu, L	1
Curley, T; Larson, S; O'Moore, PV; Scher, HI; Tong, W; Yeh, S	1
de Klerk, JM; van Dijk, A; van het Schip, AD; van Rijk, PP; Zonnenberg, BA	1
Deutsch, EA; Hertzberg, VS; Libson, KF; Maxon, HR; Moulton, JS; Samaratunga, RC; Scher, HI; Schroder, LE; Thomas, SR; Williams, CC	1
Ehrhardt, GJ; Englaro, EE; Hertzberg, VS; Maxon, HR; Moulton, JS; Samaratunga, R; Schroder, LE; Smith, H; Thomas, SR; Williams, CC	1
Ketring, AR	1
Ali, S; Deutsch, EA; Libson, K; Lukes, SJ; Maxon, HR; Thomas, SR; Williams, CC	1
Deutsch, EA; Ketring, AR; Weininger, J	1
Blijham, GH; de Klerk, JM; Han, SH; Quirijnen, JM; van Dijk, A; van het Schip, AD; van Rijk, PP; Zonnenberg, BA	1
McEwan, AJ	2
Lewington, VJ	1
Hinnefeld, JD; Hyams, DM; Maxon, HR; Moulton, JS; Samaratunga, RC; Sperling, MI; Thomas, SR; Von Kuster, LC	1
Blijham, GH; de Klerk, JM; Han, SH; Stokkel, MP; van Dijk, A; van het Schip, AD; van Rijk, PP; Zonnenberg, BA	1
Blijham, GH; de Klerk, JM; Hoekstra, A; Rutgers, DH; van Dieren, EB; van Dijk, A; van het Schip, AD; van Rijk, PP; Zonnenberg, BA	1
Blijham, GH; de Klerk, JM; Quirijnen, JM; van Dijk, A; van het Schip, AD; van Rijk, PP; Zonnenberg, BA	1
Silberstein, EB	1
Bender, H; Biersack, HJ; Dierke-Dzierzon, C; Grünwald, F; Mallmann, P; Palmedo, H; Reichmann, K; Schomburg, A; Schöneich, G; Zamorra, P	1
Blijham, GH; de Klerk, JM; Krouwer, HG; van Die, J; van Dijk, A; van het Schip, AD; van Rijk, PP; Zonnenberg, BA	1
Blijham, GH; de Klerk, JM; Han, SH; Quirijnen, JM; ten Kroode, HF; van Dijk, A; van het Schip, AD; van Rijk, PP; Zonnenberg, BA	1
Atkins, HL; Srivastava, SC	1
Geldof, AA; Newling, DW; Teule, GJ; van den Tillaar, PL	1
Hsieh, BT; Knapp, FF; Lin, CP; Lin, WY; Stabin, MG; Ting, G; Tsai, ZT; Wang, SJ; Yeh, SJ; Yen, TC	1
Botha, JM; Doman, MJ; Goedhals, L; Lötter, MG; Marais, J; Naudé, H; Otto, AC; Roodt, A; van Aswegen, A	1
Biersack, HJ; Dierke-Dzierzon, C; Müller, SC; Palmedo, H; Schoeneich, G	1
Holle, LH; Humke, U; Kirsch, CM; Oberhausen, E; Trampert, L; Ziegler, M	1
Biersack, HJ; Dierke-Dzierzon, C; Hauswirth, AE; Krebs, D; Palmedo, H	1
Lerch, H	1
Biersack, HJ; Grünwald, F; Köhler, S; Krebs, D; Palmedo, H; Wagner, U	1
Arteaga de Murphy, C; Croft, BY; Ferro-Flores, G; González-Zavala, MA; Meléndez-Alafort, L; Pimentel-González, G; Tendilla, JI	1
Blijham, GH; de Klerk, JM; Han, SH; Quirijnen, JM; van Dijk, A; van het Schip, AD; van Rijk, PP; Zonneberg, BA	1
de Rooij, L; Geldof, AA; Newling, DW; Teule, GJ; Versteegh, RT	1
Kothari, K; Noronha, OP; Pillai, MR; Samuel, AM; Shimpi, HH; Unni, PR	1
Hsieh, BT; Hsieh, JF; Knapp, FF; Lin, CP; Lin, WY; Ting, G; Wang, SJ	1
Curley, T; Daghighian, F; Goldsmith, SJ; Graham, MC; Larson, SM; Liu, GB; Scher, HI; Yeh, SD	1
Bender, H; Biersack, HJ; Carl, UM; Dierke-Dzierzon, C; Krebs, D; Palmedo, H; Risse, J	1
de Klerk, JM; Huiskes, AW; van Dijk, A; van Het Schip, AD; van Rijk, PP; Zonnenberg, BA	1
Brans, B; De Winter, F; Dierckx, RA; Van De Wiele, C	1
Hsieh, BT; Hsieh, JF; Lin, WY; Ting, G; Tsai, SC; Wang, SJ	1
Bender, H; Biersack, HJ; Grünwald, F; Guhlke, S; Knapp, FF; Palmedo, H; Risse, J; Sartor, J; Schoeneich, G	1
Spencer, RP	1
Csernay, L; Láng, J; Pajor, L; Pávics, L; Róka, R; Séra, T; Thurzó, L	1
Bohuslavizki, KH; Klutmann, S	1
Franke, WG; Grüning, T; Hliscs, R; Knapp, FF; Koch, R; Kropp, J; Liepe, K; Runge, R	1
Aras, G; Baltaci, S; Bedük, Y; Canakci, N; Ibiş, E; Küçük, NO; Ozalp, G; Soylu, A	1
Carpentier, P; Caty, A; Depreux, P; Kolesnikov-Gauthier, H; Sulman, C; Vennin, P	1
Franke, WG; Hliscs, R; Koch, R; Kropp, J; Liepe, K; Runge, R	1
Franke, WG; Hliscs, R; Kropp, J; Liepe, K	1
Brenner, W; Henze, E; Kampen, AM; Kampen, WU	1
Bergomi, S; Festa, A; Maini, CL; Pasqualoni, R; Rea, S; Sciuto, R; Semprebene, A	1
Bestagno, M; Colamussi, P; Dafermou, A; Giganti, M; Piffanelli, A; Pizzocaro, C	1
De Klerk, JM; Han, SH; Tan, S; Van Rijk, PP; Zonnenberg, BA	1
Bestagno, M; Cittanti, C; Colamussi, P; Dafermou, A; Giganti, M; Piffanelli, A	1
Banerjee, S; Chaudhari, PR; Kothari, K; Pillai, MR; Samuel, G; Sarma, HD; Unni, PR; Unnikrishnan, TP	1
Bangard, M; Biersack, HJ; Menzel, C; Palmedo, H; Risse, J; Rockstroh, JK; Schliefer, K	1
Li, S; Liu, J; Tian, M; Wang, J; Zhang, H; Zheng, X	1
Al-Deen, A; Buffa, FM; Chittenden, S; Cook, G; Dearnaley, DP; Flux, G; Gadd, J; Guy, M; Horwich, A; Huddart, RA; McCready, VR; Norman, AR; O'Sullivan, JM; Pomeroy, K; Treleaven, J	1
Blijham, GH; de Klerk, JM; Derksen, BH; Han, SH; Kruitwagen, CL; Tan, S; van Dijk, A; van het Schip, AD; van Rijk, PP; Zonnenberg, BA	1
Brenner, W; Brümmer, C; Czech, N; Henze, E; Kampen, WU; Muhle, C; von Forstner, C; Zuhayra, M	1
Jedináková-Krízová, V; Koudelková, M	1
Silberstein, EB; Taylor, AT	1
Buffa, FM; Chittenden, SJ; Dearnaley, DP; Flux, GD; Guy, MJ; McCready, VR; O'Sullivan, JM	1
Franke, WG; Hliscs, R; Knapp, FF; Kropp, J; Liepe, K; Runge, R	1
Albers, P; Biersack, HJ; Ezziddin, S; Fimmers, R; Guhlke, S; Joe, A; Knapp, FF; Manka-Waluch, A; Palmedo, H; Reinhardt, M; Roedel, R; Schmidt-Wolf, IG	1
Kotzerke, J; Kropp, J; Liepe, K; Runge, R	1
Döbert, N; Grünwald, F; Klein, SA; Kranert, WT; Martin, H; Menzel, C; Mose, S	1
Bandurski, T; Derejko, M; Romanowicz, G; Scheffler, J	1
Endo, K; Li, S; Liu, J; Tanada, S; Tian, M; Zhang, H	1
de Klerk, JM; Lam, MG; van Rijk, PP	1
Dohmen, BM; Einsele, H; Kanz, L; Wiesmann, A	1
Chen, SX; DU, JQ; Jiang, NY; Liang, JG; Liu, XG; Lu, XP	1
Buffa, FM; Coffey, J; Cook, G; Dearnaley, DP; Flux, G; Horwich, A; Huddart, RA; Johnson, B; McCready, VR; Norman, AR; O'Sullivan, JM; Parker, CC; Treleaven, J	1
Bloch, G; Chittenden, S; Dearnaley, DP; Divoli, A; Flux, GD; Malaroda, A; O'Sullivan, JM	1
El-Mabhouh, AA; Mercer, JR	1
Koutsikos, J; Leondi, A	1
de Klerk, JM; Hoekstra, A; Lam, MG; van Rijk, PP; Zonnenberg, BA	1
Bosma, TB; Lam, MG; van Rijk, PP; Zonnenberg, BA	1
Bergmann, R; Geidel, HH; Haase, M; Kotzerke, J; Liepe, K; Runge, R	1
Baziotis, N; Limouris, GS; Zafeirakis, A; Zissimopoulos, A	1
Beekman, FJ; Bloemendal, HJ; de Klerk, JMH; Hendrikse, NH; Lange, R; Ramakers, RM; Ter Heine, R; van der Westerlaken, MML	1
Bahrami Samani, A; Pourhabib, Z; Ranjbar, H	1

Reviews

7 review(s) available for rhenium and etidronate

Article	Year
Hormone refractory prostatic cancer: the role of radiolabelled diphosphonates and growth factor inhibitors. Advances in experimental medicine and biology, 1992, Volume: 324 Topics: Animals; Bone Neoplasms; Dogs; Drug Screening Assays, Antitumor; Etidronic Acid; Growth Substances; Humans; Male; Neoplasm Proteins; Organometallic Compounds; Organophosphorus Compounds; Palliative Care; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Rhenium; Samarium; Suramin	1992
Targeted radionuclide therapy for bone metastases. European journal of nuclear medicine, 1993, Volume: 20, Issue:1 Topics: Analgesics; Bone Neoplasms; Combined Modality Therapy; Etidronic Acid; Humans; Organometallic Compounds; Organophosphorus Compounds; Pain, Intractable; Palliative Care; Radioisotopes; Radiotherapy; Rhenium; Samarium; Strontium Radioisotopes	1993
Radiolabeled bone-seeking radiopharmaceuticals. The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), 1996, Volume: 40, Issue:3 Topics: Animals; Bone Neoplasms; Etidronic Acid; Female; Humans; Male; Pentetic Acid; Radioisotopes; Radiopharmaceuticals; Rhenium; Samarium; Tin	1996
Unsealed source therapy of painful bone metastases: an update. Seminars in nuclear medicine, 1997, Volume: 27, Issue:2 Topics: Bone Neoplasms; Clinical Trials as Topic; Etidronic Acid; Female; Humans; Male; Organometallic Compounds; Organophosphorus Compounds; Pain; Pain Management; Palliative Care; Pentetic Acid; Phosphorus Radioisotopes; Radioisotopes; Rhenium; Safety; Strontium Radioisotopes; Syndrome	1997
186Re-etidronate. Efficacy of palliative radionuclide therapy for painful bone metastases. The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), 2001, Volume: 45, Issue:1 Topics: Bone Neoplasms; Etidronic Acid; Female; Humans; Male; Organometallic Compounds; Pain, Intractable; Palliative Care; Radiopharmaceuticals; Rhenium; Tin Radioisotopes	2001
Application of rhenium-188 HEDP in bone metastases therapy. Nuclear medicine review. Central & Eastern Europe, 2003, Volume: 6, Issue:1 Topics: Bone Neoplasms; Etidronic Acid; Humans; Leukopenia; Organometallic Compounds; Pain; Palliative Care; Practice Patterns, Physicians'; Radiopharmaceuticals; Rhenium; Thrombocytopenia; Treatment Outcome	2003
186Re-HEDP for metastatic bone pain in breast cancer patients. European journal of nuclear medicine and molecular imaging, 2004, Volume: 31 Suppl 1 Topics: Bone Neoplasms; Breast Neoplasms; Dose-Response Relationship, Radiation; Etidronic Acid; Female; Humans; Maximum Tolerated Dose; Organometallic Compounds; Pain; Palliative Care; Radiation Injuries; Radioimmunotherapy; Radiopharmaceuticals; Radiotherapy Dosage; Rhenium; Treatment Outcome	2004

Trials

28 trial(s) available for rhenium and etidronate

Article	Year
Hormone refractory prostatic cancer: the role of radiolabelled diphosphonates and growth factor inhibitors. Advances in experimental medicine and biology, 1992, Volume: 324 Topics: Animals; Bone Neoplasms; Dogs; Drug Screening Assays, Antitumor; Etidronic Acid; Growth Substances; Humans; Male; Neoplasm Proteins; Organometallic Compounds; Organophosphorus Compounds; Palliative Care; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Rhenium; Samarium; Suramin	1992
Rhenium-186(Sn)HEDP for treatment of painful osseous metastases: results of a double-blind crossover comparison with placebo. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1991, Volume: 32, Issue:10 Topics: Aged; Bone Neoplasms; Double-Blind Method; Etidronic Acid; Female; Humans; Male; Organometallic Compounds; Pain, Intractable; Palliative Care; Prostatic Neoplasms; Radioisotopes; Rhenium; Technetium Tc 99m Medronate	1991
Dose escalation study of rhenium-186 hydroxyethylidene diphosphonate in patients with metastatic prostate cancer. European journal of nuclear medicine, 1994, Volume: 21, Issue:10 Topics: Aged; Bone Neoplasms; Etidronic Acid; Humans; Male; Organometallic Compounds; Palliative Care; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Rhenium; Thrombocytopenia	1994
Phase 1 study of rhenium-186-HEDP in patients with bone metastases originating from breast cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1996, Volume: 37, Issue:2 Topics: Alkaline Phosphatase; Bone Neoplasms; Breast Neoplasms; Carcinoembryonic Antigen; Dose-Response Relationship, Radiation; Etidronic Acid; Female; Follow-Up Studies; Humans; Middle Aged; Palliative Care; Radioisotopes; Rhenium; Thrombocytopenia	1996
Dosage and response in radiopharmaceutical therapy of painful osseous metastases. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1996, Volume: 37, Issue:2 Topics: Bone Neoplasms; Breast Neoplasms; Dose-Response Relationship, Radiation; Etidronic Acid; Female; Humans; Male; Palliative Care; Prostatic Neoplasms; Radioisotopes; Rhenium; Thrombocytopenia	1996
[Pain therapy with rhenium-186 HEDP in multiple bone metastases]. Nuklearmedizin. Nuclear medicine, 1996, Volume: 35, Issue:2 Topics: Bone Neoplasms; Breast Neoplasms; Diphosphonates; Etidronic Acid; Female; Humans; Male; Neoplasm Metastasis; Organometallic Compounds; Organotechnetium Compounds; Pain; Palliative Care; Prostatic Neoplasms; Radioisotopes; Rhenium; Time Factors; Tomography, Emission-Computed	1996
Efficacy of rhenium-186-etidronate in prostate cancer patients with metastatic bone pain. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1996, Volume: 37, Issue:9 Topics: Bone Neoplasms; Etidronic Acid; Humans; Male; Pain Measurement; Palliative Care; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Rhenium; Time Factors	1996
Rhenium-186 HEDP: palliative radionuclide therapy of painful bone metastases. Preliminary results. Scandinavian journal of urology and nephrology, 1997, Volume: 31, Issue:5 Topics: Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Male; Organometallic Compounds; Pain Measurement; Palliative Care; Prostatic Neoplasms; Radioisotopes; Rhenium; Time Factors	1997
186Re-etidronate in breast cancer patients with metastatic bone pain. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1999, Volume: 40, Issue:4 Topics: Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Organometallic Compounds; Pain, Intractable; Palliative Care; Radioisotopes; Rhenium	1999
Rhenium-186-labeled hydroxyethylidene diphosphonate dosimetry and dosing guidelines for the palliation of skeletal metastases from androgen-independent prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 1999, Volume: 5, Issue:6 Topics: Androgens; Bone Neoplasms; Dose-Response Relationship, Radiation; Etidronic Acid; Humans; Kidney; Male; Metabolic Clearance Rate; Organometallic Compounds; Palliative Care; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Whole-Body Counting	1999
Can bone marrow scintigraphy predict platelet toxicity after treatment with 186Re-HEDP? Nuclear medicine communications, 1999, Volume: 20, Issue:9 Topics: Aged; Blood Platelets; Bone and Bones; Bone Marrow; Bone Marrow Neoplasms; Diphosphonates; Etidronic Acid; Humans; Male; Organometallic Compounds; Organotechnetium Compounds; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Thrombocytopenia	1999
Dose escalation study with rhenium-188 hydroxyethylidene diphosphonate in prostate cancer patients with osseous metastases. European journal of nuclear medicine, 2000, Volume: 27, Issue:2 Topics: Bone Neoplasms; Dose-Response Relationship, Radiation; Etidronic Acid; Humans; Male; Pain Measurement; Pain, Intractable; Palliative Care; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Rhenium	2000
[Clinical experience with rhenium-188 HEDP therapy for metastatic bone pain]. Orvosi hetilap, 2000, May-07, Volume: 141, Issue:19 Topics: Alkaline Phosphatase; Analgesics; Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Male; Pain; Pain Measurement; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Rhenium; Treatment Outcome	2000
Evaluation of toxicity and efficacy of 186Re-hydroxyethylidene diphosphonate in patients with painful bone metastases of prostate or breast cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2000, Volume: 41, Issue:10 Topics: Adenocarcinoma; Aged; Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Male; Middle Aged; Organometallic Compounds; Palliative Care; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Rhenium; Time Factors	2000
[Comparison of rhenium-188, rhenium-186-HEDP and strontium-89 in palliation of painful bone metastases]. Nuklearmedizin. Nuclear medicine, 2000, Volume: 39, Issue:6 Topics: Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Leukocyte Count; Male; Middle Aged; Organometallic Compounds; Pain; Palliative Care; Platelet Count; Prostatic Neoplasms; Radioisotopes; Rhenium; Strontium Radioisotopes; Tomography, X-Ray Computed	2000
Metastatic bone pain palliation with 89-Sr and 186-Re-HEDP in breast cancer patients. Breast cancer research and treatment, 2001, Volume: 66, Issue:2 Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Disease-Free Survival; Etidronic Acid; Female; Humans; Infusions, Intravenous; Karnofsky Performance Status; Middle Aged; Organometallic Compounds; Pain Measurement; Pain, Intractable; Palliative Care; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Strontium Radioisotopes; Treatment Outcome	2001
Radionuclide therapy for painful bone metastases. An Italian multicentre observational study. Writing Committee of an Ad Hoc Study Group. The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), 2001, Volume: 45, Issue:1 Topics: Bone Neoplasms; Etidronic Acid; Humans; Male; Organometallic Compounds; Pain, Intractable; Palliative Care; Prostatic Neoplasms; Radiopharmaceuticals; Rhenium; Strontium; Strontium Radioisotopes; Tin Radioisotopes	2001
Painful multifocal arthritis: therapy with rhenium 186 hydroxyethylidenediphosphonate ((186)Re HEDP) after failed treatment with medication--initial results of a prospective study. Radiology, 2001, Volume: 221, Issue:1 Topics: Arthritis, Rheumatoid; Etidronic Acid; Female; Humans; Male; Middle Aged; Organometallic Compounds; Pain; Pain Management; Prospective Studies; Radioisotopes; Rhenium; Treatment Failure	2001
High activity Rhenium-186 HEDP with autologous peripheral blood stem cell rescue: a phase I study in progressive hormone refractory prostate cancer metastatic to bone. British journal of cancer, 2002, Jun-05, Volume: 86, Issue:11 Topics: Bone and Bones; Bone Neoplasms; Combined Modality Therapy; Disease Progression; Etidronic Acid; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Organometallic Compounds; Prostate-Specific Antigen; Prostatic Neoplasms; Radionuclide Imaging; Radiotherapy; Recombinant Proteins; Rhenium	2002
The PLACORHEN study: a double-blind, placebo-controlled, randomized radionuclide study with (186)Re-etidronate in hormone-resistant prostate cancer patients with painful bone metastases. Placebo Controlled Rhenium Study. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2002, Volume: 43, Issue:9 Topics: Aged; Bone Neoplasms; Double-Blind Method; Etidronic Acid; Humans; Male; Organometallic Compounds; Pain Measurement; Palliative Care; Prostatic Neoplasms; Radiopharmaceuticals; Rhenium; Tin Radioisotopes	2002
A model-based method for the prediction of whole-body absorbed dose and bone marrow toxicity for 186Re-HEDP treatment of skeletal metastases from prostate cancer. European journal of nuclear medicine and molecular imaging, 2003, Volume: 30, Issue:8 Topics: Body Burden; Bone Marrow; Bone Neoplasms; Computer Simulation; Etidronic Acid; Humans; Injections, Intravenous; Male; Models, Biological; Organometallic Compounds; Prognosis; Prostate-Specific Antigen; Prostatic Neoplasms; Radiometry; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Relative Biological Effectiveness; Rhenium; Statistics as Topic; Treatment Outcome; Whole-Body Counting	2003
Dosimetry of 188Re-hydroxyethylidene diphosphonate in human prostate cancer skeletal metastases. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2003, Volume: 44, Issue:6 Topics: Aged; Aged, 80 and over; Body Burden; Bone Marrow; Bone Neoplasms; Etidronic Acid; Half-Life; Humans; Injections, Intravenous; Kidney; Male; Metabolic Clearance Rate; Middle Aged; Organometallic Compounds; Prostatic Neoplasms; Radiation Dosage; Radiometry; Rhenium; Tissue Distribution; Urinary Bladder; Whole-Body Counting	2003
Repeated bone-targeted therapy for hormone-refractory prostate carcinoma: tandomized phase II trial with the new, high-energy radiopharmaceutical rhenium-188 hydroxyethylidenediphosphonate. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Aug-01, Volume: 21, Issue:15 Topics: Aged; Bone Neoplasms; Disease Progression; Dose-Response Relationship, Radiation; Etidronic Acid; Humans; Male; Organometallic Compounds; Pain Measurement; Pain, Intractable; Palliative Care; Prospective Studies; Prostatic Neoplasms; Radiotherapy Dosage; Rhenium; Treatment Outcome	2003
Therapeutic efficiency of rhenium-188-HEDP in human prostate cancer skeletal metastases. British journal of cancer, 2003, Aug-18, Volume: 89, Issue:4 Topics: Aged; Aged, 80 and over; Blood Cell Count; Bone Neoplasms; Etidronic Acid; Humans; Male; Middle Aged; Neoplasm Staging; Organometallic Compounds; Pain; Pain Measurement; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Rhenium; Treatment Outcome	2003
[Clinical value of combined therapy with 188Re-HEDP and pamidronate in breast cancer with bone metastasis]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2005, Volume: 27, Issue:3 Topics: Adult; Aged; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Carcinoembryonic Antigen; Combined Modality Therapy; Diphosphonates; Etidronic Acid; Female; Follow-Up Studies; Humans; Middle Aged; Organometallic Compounds; Pain; Pain Management; Pamidronate; Radioisotopes; Rhenium	2005
A phase 2 study of high-activity 186Re-HEDP with autologous peripheral blood stem cell transplant in progressive hormone-refractory prostate cancer metastatic to bone. European journal of nuclear medicine and molecular imaging, 2006, Volume: 33, Issue:9 Topics: Aged; Bone Neoplasms; Combined Modality Therapy; Drug Resistance, Neoplasm; Etidronic Acid; Humans; Male; Middle Aged; Organometallic Compounds; Peripheral Blood Stem Cell Transplantation; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Rhenium; Transplantation, Autologous	2006
Tumor dosimetry on SPECT (186)Re-HEDP scans: variations in the results from the reconstruction methods used. Cancer biotherapy & radiopharmaceuticals, 2007, Volume: 22, Issue:1 Topics: Bone Neoplasms; Dose-Response Relationship, Radiation; Etidronic Acid; Humans; Male; Prostatic Neoplasms; Radioisotopes; Rhenium; Tomography, Emission-Computed, Single-Photon	2007
(188)Re-HEDP combined with capecitabine in hormone-refractory prostate cancer patients with bone metastases: a phase I safety and toxicity study. European journal of nuclear medicine and molecular imaging, 2009, Volume: 36, Issue:9 Topics: Aged; Aged, 80 and over; Bone Neoplasms; Capecitabine; Deoxycytidine; Drug Resistance, Neoplasm; Etidronic Acid; Fluorouracil; Humans; Male; Middle Aged; Prostatic Neoplasms; Radiation-Sensitizing Agents; Radioisotopes; Radiopharmaceuticals; Rhenium	2009

Other Studies

47 other study(ies) available for rhenium and etidronate

Article	Year
Preparation of rhenium-186 labelled EHDP and its possible use in the treatment of osseous neoplasms. The International journal of applied radiation and isotopes, 1979, Volume: 30, Issue:12 Topics: Animals; Bone Neoplasms; Etidronic Acid; Isotope Labeling; Radioisotopes; Radionuclide Imaging; Rats; Rhenium; Technology, Pharmaceutical; Tissue Distribution	1979
Pharmacokinetics of rhenium-186 after administration of rhenium-186-HEDP to patients with bone metastases. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1992, Volume: 33, Issue:5 Topics: Aged; Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Half-Life; Humans; Male; Middle Aged; Palliative Care; Prostatic Neoplasms; Radioisotopes; Rhenium	1992
Re-186(Sn) HEDP for treatment of painful osseous metastases: initial clinical experience in 20 patients with hormone-resistant prostate cancer. Radiology, 1990, Volume: 176, Issue:1 Topics: Adenocarcinoma; Aged; Bone Neoplasms; Estrogens; Etidronic Acid; Humans; Male; Organometallic Compounds; Pain; Palliative Care; Prostatic Neoplasms; Quality of Life; Radioisotopes; Radiotherapy Dosage; Rhenium; Tin	1990
153Sm-EDTMP and 186Re-HEDP as bone therapeutic radiopharmaceuticals. International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology, 1987, Volume: 14, Issue:3 Topics: Animals; Bone Neoplasms; Dogs; Etidronic Acid; Humans; Kinetics; Organophosphorus Compounds; Pain; Rabbits; Radioisotopes; Radionuclide Imaging; Rhenium; Samarium; Technetium Tc 99m Medronate; Tissue Distribution	1987
Re-186(Sn) HEDP for treatment of multiple metastatic foci in bone: human biodistribution and dosimetric studies. Radiology, 1988, Volume: 166, Issue:2 Topics: Adult; Aged; Bone Neoplasms; Etidronic Acid; Female; Humans; Male; Middle Aged; Radioisotopes; Radiotherapy Dosage; Rhenium; Tissue Distribution	1988
186Re-HEDP: a potential therapeutic bone agent. Nuklearmedizin. Nuclear medicine, 1984, Volume: 23, Issue:2 Topics: Animals; Bone and Bones; Bone Neoplasms; Dogs; Etidronic Acid; Mice; Radioisotopes; Radionuclide Imaging; Rats; Rhenium	1984
Pain palliation and nuclear medicine. European journal of nuclear medicine, 1993, Volume: 20, Issue:1 Topics: Bone Neoplasms; Etidronic Acid; Humans; Organometallic Compounds; Organophosphorus Compounds; Pain, Intractable; Palliative Care; Radioisotopes; Rhenium; Samarium; Strontium Radioisotopes	1993
A Monte Carlo simulation model for radiation dose to metastatic skeletal tumor from rhenium-186(Sn)-HEDP. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1995, Volume: 36, Issue:2 Topics: Algorithms; Autoradiography; Bone Neoplasms; Etidronic Acid; Humans; Monte Carlo Method; Organometallic Compounds; Radiation Dosage; Radioisotopes; Rhenium; Tin	1995
Evaluation of thrombocytopenia in patients treated with rhenium-186-HEDP: guidelines for individual dosage recommendations. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1994, Volume: 35, Issue:9 Topics: Aged; Aged, 80 and over; Bone Neoplasms; Dose-Response Relationship, Radiation; Etidronic Acid; Humans; Male; Middle Aged; Platelet Count; Prostatic Neoplasms; Radioisotopes; Rhenium; Thrombocytopenia	1994
Bone marrow absorbed dose of rhenium-186-HEDP and the relationship with decreased platelet counts. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1996, Volume: 37, Issue:1 Topics: Aged; Bone Marrow; Bone Neoplasms; Dose-Response Relationship, Radiation; Etidronic Acid; Humans; Male; Palliative Care; Platelet Count; Prostatic Neoplasms; Radiation Dosage; Radioisotopes; Rhenium; Thrombocytopenia	1996
Transient cranial neuropathy in prostatic cancer with bone metastases after rhenium-186-HEDP treatment. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1996, Volume: 37, Issue:3 Topics: Bone Neoplasms; Cranial Nerve Diseases; Etidronic Acid; Glossopharyngeal Nerve; Humans; Hypoglossal Nerve; Male; Mandibular Nerve; Middle Aged; Palliative Care; Prostatic Neoplasms; Radioisotopes; Rhenium; Time Factors	1996
Radionuclide therapy for prostate cancer lumbar metastasis prolongs symptom-free survival in a rat model. Urology, 1997, Volume: 49, Issue:5 Topics: Animals; Etidronic Acid; Lumbar Vertebrae; Male; Prostatic Neoplasms; Radioisotopes; Rats; Rhenium; Spinal Neoplasms; Survival Rate	1997
Rhenium-188 hydroxyethylidene diphosphonate: a new generator-produced radiotherapeutic drug of potential value for the treatment of bone metastases. European journal of nuclear medicine, 1997, Volume: 24, Issue:6 Topics: Animals; Bone Neoplasms; Etidronic Acid; Half-Life; Humans; Male; Rabbits; Radiation Dosage; Radioisotopes; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rhenium; Tissue Distribution	1997
Radiation dose estimates of 186Re-hydroxyethylidene diphosphonate for palliation of metastatic osseous lesions: an animal model study. Nuclear medicine communications, 1997, Volume: 18, Issue:6 Topics: Adult; Animals; Bone and Bones; Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Kidney; Male; Metabolic Clearance Rate; Organometallic Compounds; Palliative Care; Papio; Prostatic Neoplasms; Radiopharmaceuticals; Rhenium; Tissue Distribution; Urinary Bladder	1997
[Palliative treatment for pain in osseous metastasized prostatic carcinoma with osteotropic rhenium-186 hydroxyethylidene diphosphonate (HEDP)]. Der Urologe. Ausg. A, 1997, Volume: 36, Issue:6 Topics: Aged; Aged, 80 and over; Bone Neoplasms; Diphosphonates; Etidronic Acid; Humans; Male; Middle Aged; Organometallic Compounds; Organotechnetium Compounds; Pain; Palliative Care; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy; Rhenium	1997
[Pain therapy in multiple bone metastases in breast carcinoma with rhenium 186 HEDP]. Zentralblatt fur Gynakologie, 1998, Volume: 120, Issue:2 Topics: Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Middle Aged; Pain Measurement; Palliative Care; Quality of Life; Radioisotopes; Radionuclide Imaging; Rhenium; Treatment Outcome	1998
[Advanced prostate carcinoma: systemic radionuclide therapy of bone metastasis with rhenium-168-hydroxyethylidine diphosphonate]. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 1998, Volume: 174, Issue:7 Topics: Bone Neoplasms; Etidronic Acid; Humans; Male; Pain Measurement; Palliative Care; Prostatic Neoplasms; Radioisotopes; Rhenium; Treatment Outcome	1998
Remission of bone metastases after combined chemotherapy and radionuclide therapy with Re-186 HEDP. Clinical nuclear medicine, 1998, Volume: 23, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Therapy; Etidronic Acid; Female; Humans; Middle Aged; Palliative Care; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Technetium Tc 99m Medronate	1998
Preparation, biodistribution, and dosimetry of 188Re-labeled MoAb ior cea1 and its F(ab')2 fragments by avidin-biotin strategy. Nuclear medicine and biology, 1999, Volume: 26, Issue:1 Topics: Animals; Antibodies, Monoclonal; Avidin; Biotin; Carcinoembryonic Antigen; Etidronic Acid; Female; Immunoconjugates; Immunoglobulin Fab Fragments; Immunoglobulin G; Ligands; Mice; Mice, Inbred BALB C; Rhenium; Tissue Distribution	1999
Combination 186Re-HEDP and cisplatin supra-additive treatment effects in prostate cancer cells. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1999, Volume: 40, Issue:4 Topics: Animals; Cisplatin; Combined Modality Therapy; Drug Screening Assays, Antitumor; Etidronic Acid; Male; Organometallic Compounds; Prostatic Neoplasms; Radiation-Sensitizing Agents; Radioisotopes; Rats; Rhenium; Tumor Cells, Cultured	1999
Preparation, stability studies and pharmacological behavior of [186Re]Re-HEDP. Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 1999, Volume: 51, Issue:1 Topics: Animals; Chromatography, Thin Layer; Drug Stability; Etidronic Acid; Hydrogen-Ion Concentration; Isotope Labeling; Male; Organometallic Compounds; Radioisotopes; Radiopharmaceuticals; Rats; Rats, Wistar; Rhenium; Tissue Distribution	1999
Effect of reaction conditions on preparations of rhenium-188 hydroxyethylidene diphosphonate complexes. Nuclear medicine and biology, 1999, Volume: 26, Issue:4 Topics: Animals; Drug Stability; Etidronic Acid; Hydrogen-Ion Concentration; Isotope Labeling; Male; Rats; Rats, Sprague-Dawley; Rhenium; Tissue Distribution	1999
Pain palliation with rhenium-186 HEDP in breast cancer patients with disseminated bone metastases. Clinical nuclear medicine, 1999, Volume: 24, Issue:9 Topics: Adult; Aged; Analgesics; Blood Cell Count; Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Injections, Intravenous; Middle Aged; Pain; Pain Measurement; Palliative Care; Radioisotopes; Radionuclide Imaging; Rhenium; Treatment Outcome	1999
Visualization of the stomach on rhenium-186 HEDP imaging after therapy for metastasized prostate carcinoma. Clinical nuclear medicine, 1999, Volume: 24, Issue:11 Topics: Aged; Bone Neoplasms; Etidronic Acid; Humans; Male; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Rhenium; Stomach	1999
Comparison of various rhenium-188-labeled diphosphonates for the treatment of bone metastases. Nuclear medicine and biology, 1999, Volume: 26, Issue:8 Topics: Animals; Bone and Bones; Bone Neoplasms; Diphosphonates; Etidronic Acid; Injections, Intravenous; Isotope Labeling; Neoplasm Metastasis; Organometallic Compounds; Rabbits; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Soft Tissue Neoplasms; Tissue Distribution; Whole-Body Counting	1999
Quantifying leukocyte and thrombocyte suppression-recovery after Re-186 HEDP for bone metastases. Clinical nuclear medicine, 2000, Volume: 25, Issue:6 Topics: Blood Platelets; Bone Marrow; Bone Neoplasms; Breast Neoplasms; Carcinoma; Etidronic Acid; Female; Follow-Up Studies; Forecasting; Humans; Leukocyte Count; Leukocytes; Leukopenia; Organometallic Compounds; Platelet Count; Radiopharmaceuticals; Rhenium; Thrombocytopenia; Tin Radioisotopes	2000
[Palliation of bone pain in metastatic prostate carcinoma. Value of radionuclide therapy with rhenium 186 HEDP]. MMW Fortschritte der Medizin, 1999, Nov-04, Volume: 141, Issue:44 Topics: Aged; Bone Neoplasms; Etidronic Acid; Humans; Male; Organometallic Compounds; Palliative Care; Prostatic Neoplasms; Radioisotopes; Rhenium; Treatment Outcome	1999
Rhenium-188-HEDP in the palliative treatment of bone metastases. Cancer biotherapy & radiopharmaceuticals, 2000, Volume: 15, Issue:3 Topics: Aged; Bone Neoplasms; Etidronic Acid; Female; Humans; Male; Middle Aged; Organometallic Compounds; Palliative Care; Radioisotopes; Rhenium	2000
Palliative analgesic effect of Re-186 HEDP in various cancer patients with bone metastases. Annals of nuclear medicine, 2000, Volume: 14, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nasopharyngeal Neoplasms; Organometallic Compounds; Pain; Palliative Care; Prostatic Neoplasms; Radiopharmaceuticals; Rectal Neoplasms; Rhenium	2000
Significant reduction of the mass of bone metastasis 1 year after rhenium-186 HEDP pain palliation therapy. Clinical nuclear medicine, 2000, Volume: 25, Issue:11 Topics: Bone Neoplasms; Etidronic Acid; Humans; Male; Middle Aged; Organometallic Compounds; Pain; Palliative Care; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Technetium Tc 99m Medronate	2000
Skeletal uptake and soft-tissue retention of 186Re-HEDP and 153Sm-EDTMP in patients with metastatic bone disease. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2001, Volume: 42, Issue:2 Topics: Aged; Bone and Bones; Bone Neoplasms; Etidronic Acid; Female; Humans; Male; Middle Aged; Muscle, Skeletal; Organometallic Compounds; Organophosphorus Compounds; Pain Management; Palliative Care; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Samarium; Thigh; Urinary Bladder	2001
A multicentre observational study of radionuclide therapy in patients with painful bone metastases of prostate cancer. European journal of nuclear medicine, 2001, Volume: 28, Issue:7 Topics: Aged; Aged, 80 and over; Bone Neoplasms; Etidronic Acid; Humans; Injections, Intravenous; Male; Middle Aged; Organometallic Compounds; Pain; Pain Measurement; Palliative Care; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Strontium; Strontium Radioisotopes	2001
186Re-1,4,8,11-tetraaza cyclotetradecyl-1,4,8,11-tetramethylene phosphonic acid: a novel agent for possible use in metastatic bone-pain palliation. Nuclear medicine and biology, 2001, Volume: 28, Issue:6 Topics: Analgesics; Animals; Bone Neoplasms; Etidronic Acid; Heterocyclic Compounds, 1-Ring; Injections, Intravenous; Male; Organometallic Compounds; Organophosphonates; Pain; Rabbits; Rats; Rats, Sprague-Dawley; Rhenium; Tissue Distribution	2001
Rhenium-188 HEDP to treat painful bone metastases. Clinical nuclear medicine, 2001, Volume: 26, Issue:11 Topics: Bone Neoplasms; Etidronic Acid; Female; Follow-Up Studies; Humans; Leukocyte Count; Male; Middle Aged; Organometallic Compounds; Pain; Pain Management; Palliative Care; Platelet Count; Radionuclide Imaging; Radiopharmaceuticals; Rhenium	2001
Bone uptake studies in rabbits before and after high-dose treatment with 153Sm-EDTMP or 186Re-HEDP. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2003, Volume: 44, Issue:2 Topics: Animals; Bone and Bones; Connective Tissue; Etidronic Acid; Female; Organometallic Compounds; Organophosphorus Compounds; Rabbits; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Technetium Tc 99m Medronate; Urinary Bladder; Whole-Body Counting	2003
Capillary electrophoretic and thin-layer chromatographic characterization of rhenium complexation with 1-hydroxyethylidenediphosphonic acid. Journal of chromatography. A, 2003, Mar-21, Volume: 990, Issue:1-2 Topics: Chromatography, Thin Layer; Electrophoresis, Capillary; Etidronic Acid; Hydrogen-Ion Concentration; Kinetics; Ligands; Rhenium	2003
EANM procedure guidelines for treatment of refractory metastatic bone pain. European journal of nuclear medicine and molecular imaging, 2003, Volume: 30, Issue:3 Topics: Bone Neoplasms; Etidronic Acid; Europe; Humans; Nuclear Medicine; Organometallic Compounds; Organophosphorus Compounds; Pain, Intractable; Palliative Care; Patient Selection; Radiopharmaceuticals; Radiotherapy; Rhenium; Societies, Medical; Treatment Outcome	2003
Re-186 HEDP conditioning therapy in patients with advanced acute lymphoblastic leukemia before allogeneic bone marrow transplantation. Clinical nuclear medicine, 2003, Volume: 28, Issue:9 Topics: Adult; Bone Marrow Transplantation; Etidronic Acid; Humans; Kidney; Male; Organometallic Compounds; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Rhenium; Transplantation Conditioning	2003
Rhenium-188-HEDP therapy for the palliation of pain due to osseous metastases in lung cancer patients. Cancer biotherapy & radiopharmaceuticals, 2003, Volume: 18, Issue:5 Topics: Adult; Aged; Bone Neoplasms; Dose-Response Relationship, Radiation; Etidronic Acid; Female; Follow-Up Studies; Humans; Leukocyte Count; Lung Neoplasms; Male; Middle Aged; Organometallic Compounds; Pain; Palliative Care; Radionuclide Imaging; Rhenium	2003
Complete remission after myeloablation with bone-seeking 186Re-HEDP and high-dose melphalan followed by autologous stem cell transplantation in a patient with chemorefractory multiple myeloma. Bone marrow transplantation, 2005, Volume: 36, Issue:1 Topics: Bone and Bones; Disease-Free Survival; Etidronic Acid; Humans; Melphalan; Middle Aged; Multiple Myeloma; Myeloablative Agonists; Organometallic Compounds; Peripheral Blood Stem Cell Transplantation; Radioisotopes; Remission Induction; Rhenium; Salvage Therapy; Transplantation, Autologous	2005
188Re-labelled gemcitabine/bisphosphonate (Gem/BP): a multi-functional, bone-specific agent as a potential treatment for bone metastases. European journal of nuclear medicine and molecular imaging, 2008, Volume: 35, Issue:7 Topics: Animals; Bone and Bones; Bone Neoplasms; Cattle; Combined Modality Therapy; Deoxycytidine; Diphosphonates; Durapatite; Etidronic Acid; Female; Gemcitabine; Humans; In Vitro Techniques; Mice; Mice, Inbred BALB C; Organometallic Compounds; Radioisotopes; Radiopharmaceuticals; Rhenium; Tissue Distribution	2008
Treatment efficacy of combined biphosphonates and 186Re-HEDP treatment in cancer patients with bone metastases. European journal of nuclear medicine and molecular imaging, 2008, Volume: 35, Issue:7 Topics: Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Combined Modality Therapy; Diphosphonates; Etidronic Acid; Female; Humans; Male; Organometallic Compounds; Organophosphorus Compounds; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Rhenium	2008
Radiation safety considerations for the bone seeking radiopharmaceuticals. 89SrCl2, 186Re-HEDP and 153Sm-EDTMP. Nuklearmedizin. Nuclear medicine, 2009, Volume: 48, Issue:1 Topics: Adult; Aged; Bone and Bones; Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Organometallic Compounds; Organophosphorus Compounds; Prostatic Neoplasms; Radiation Injuries; Radioisotopes; Rhenium; Safety; Samarium; Strontium; Strontium Radioisotopes	2009
Autoradiographic studies of rhenium-188-hydroxyethylidine diphosphonate in normal skeleton and osteoblastic bone metastases in a rat model of metastatic prostate cancer. Nuclear medicine communications, 2009, Volume: 30, Issue:9 Topics: Animals; Autoradiography; Bone and Bones; Bone Neoplasms; Cell Line, Tumor; Disease Models, Animal; Etidronic Acid; Lumbar Vertebrae; Male; Osteoblasts; Prostatic Neoplasms; Radioisotopes; Rats; Rhenium; Tissue Distribution	2009
Introduction of a new semi-quantitative index with predictive implications in patients with painful osseous metastases after (186)Re-HEDP therapy. The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2011, Volume: 55, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Organometallic Compounds; Pain; Pain Measurement; Predictive Value of Tests; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Rhenium	2011
Drug composition matters: the influence of carrier concentration on the radiochemical purity, hydroxyapatite affinity and in-vivo bone accumulation of the therapeutic radiopharmaceutical 188Rhenium-HEDP. Nuclear medicine and biology, 2015, Volume: 42, Issue:5 Topics: Animals; Bone and Bones; Durapatite; Etidronic Acid; Male; Mice; Mice, Inbred C57BL; Radiochemistry; Radioisotopes; Radiopharmaceuticals; Rhenium; Tissue Distribution	2015
ESTIMATION OF HUMAN DOSE OF 188/186RE-HEDP COCKTAIL BASED ON OLINDA/EXM AND DISTRIBUTION DATA IN RATS. Radiation protection dosimetry, 2020, Aug-28, Volume: 190, Issue:2 Topics: Bone Neoplasms; Etidronic Acid; Humans; Radioisotopes; Radiopharmaceuticals; Rhenium; Tissue Distribution	2020